USFDA completes inspection at Laurus Labs’ Unit 4 in Visakhapatnam

12 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has successfully completed inspection at Laurus Labs’ Unit 4 at Visakhapatnam, Andhra Pradesh, without any observations and no form 483 issued. The inspection was carried out from July 08, 2019-July 12, 2019.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1014.90 -3.20 (-0.31%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×